Literature DB >> 3098880

Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.

H J Kempen, C M van Gent, R Buytenhek, B Buis.   

Abstract

We examined the association of cholesterol levels in serum lipoprotein fractions, as well as of serum apolipoprotein-AI (apo-AI) and apo-AII levels, with coronary artery stenosis (CAS) and left ventricle function in a group of 43 patients with angina pectoris (33 men and 10 women) subjected to angiography. Cholesterol level in VLDL, LDL, HDL2, and HDL3 fractions was determined after separation of these fractions by density gradient ultracentrifugation. HDL-cholesterol is the sum of cholesterol in HDL2 and HDL3. Cineangiography yielded scores for CAS and for left ventricle ejection fraction (LVEF). On univariate regression CAS was correlated weakly with LDL-cholesterol (positive) and with HDL3-cholesterol and HDL-cholesterol (negative), and more strongly with LDL-cholesterol/HDL-cholesterol (positive), but not with HDL2-cholesterol. LVEF was correlated positively with HDL3-cholesterol, HDL-cholesterol, apo-AI, and apo-AII. Of other "risk factors," none was correlated with CAS, and a history of previous myocardial infarction (PMI) was the only one significantly correlated with LVEF. CAS itself was also correlated negatively with LVEF. In multiple regression analysis with two or three independent variables, the relation of HDL(3)-cholesterol with CAS remained significant when other risk factors were taken into account. LVEF remained related positively with HDL(3)-cholesterol, apo-AI, or apo-AII, when either of them was tested in combination with other risk factors; of these only PMI made a significant independent contribution. Conclusions for this patient group (with low HDL-cholesterol): HDL3-cholesterol, and not HDL2-cholesterol, is informative for CAS; HDL(3)-cholesterol, apo-AI, or apo-AII, as well as CAS and PMI, are associated with LVEF.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3098880

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  8 in total

1.  Evidence for linkage of the apolipoprotein A-II locus to plasma apolipoprotein A-II and free fatty acid levels in mice and humans.

Authors:  C H Warden; A Daluiski; X Bu; D A Purcell-Huynh; C De Meester; B H Shieh; D L Puppione; R M Gray; G M Reaven; Y D Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

2.  Lipid lowering and HDL raising gene transfer increase endothelial progenitor cells, enhance myocardial vascularity, and improve diastolic function.

Authors:  Stephanie C Gordts; Eline Van Craeyveld; Ilayaraja Muthuramu; Neha Singh; Frank Jacobs; Bart De Geest
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

3.  Association of High-Density Lipoprotein Subclasses with Carotid Intima-Media Thickness: Shimane CoHRE Study.

Authors:  Yoshitomo Notsu; Shozo Yano; Miwako Takeda; Masayuki Yamasaki; Minoru Isomura; Toru Nabika; Atsushi Nagai
Journal:  J Atheroscler Thromb       Date:  2017-04-27       Impact factor: 4.928

4.  Association between Cardiac Remodeling and Metabolic Alteration in an Experimental Model of Obesity Induced by Western Diet.

Authors:  Artur Junio Togneri Ferron; Fabiane Valentini Francisqueti; Igor Otávio Minatel; Carol Cristina Vágula de Almeida Silva; Silméia Garcia Zanati Bazan; Koody André Hassemi Kitawara; Jéssica Leite Garcia; Camila Renata Corrêa; Fernando Moreto; Ana Lucia A Ferreira
Journal:  Nutrients       Date:  2018-11-05       Impact factor: 5.717

5.  Beneficial effects of selective HDL-raising gene transfer on survival, cardiac remodelling and cardiac function after myocardial infarction in mice.

Authors:  S C Gordts; I Muthuramu; E Nefyodova; F Jacobs; E Van Craeyveld; B De Geest
Journal:  Gene Ther       Date:  2013-06-13       Impact factor: 5.250

Review 6.  Protective Effects of HDL Against Ischemia/Reperfusion Injury.

Authors:  Monica Gomaraschi; Laura Calabresi; Guido Franceschini
Journal:  Front Pharmacol       Date:  2016-01-25       Impact factor: 5.810

7.  Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial.

Authors:  Ruben N Eppinga; Minke H T Hartman; Dirk J van Veldhuisen; Chris P H Lexis; Margery A Connelly; Erik Lipsic; Iwan C C van der Horst; Pim van der Harst; Robin P F Dullaart
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

8.  Factors influencing left ventricular ejection fraction in patients with coronary microvascular disease and obstructive coronary artery disease.

Authors:  Henry Anselmo Mayala; Magesa Mafuru; Abdalah Mkangala; Mark Mayala; Pedro Pallangyo; Dickson Minja; Mohamed Janabi; Wang Zhao-Hui
Journal:  BMC Res Notes       Date:  2020-03-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.